Does positive peritoneal cytology not affect the prognosis for stage I uterine endometrial cancer? The remaining controversy and review of the literature

International Journal of Gynecological Cancer

Volumn 24, Issue 3, 2014, Pages 549-555

  Shiozaki, Takaya ^a   Tabata, Tsutomu ^a   Yamada, Tomomi ^b   Yamamoto, Yuka ^a   Yamawaki, Takaharu ^c   Ikeda, Tomoaki ^a  

^a MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c ISE RED CROSS HOSPITAL   (Japan)

Author keywords

Endometrial cancer; Positive peritoneal cytology; Prognostic factor; Progression free survival

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; ASCITES FLUID CYTOLOGY; BLOOD VESSEL PERMEABILITY; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; ENDOMETRIUM CANCER; FEMALE; HISTOPATHOLOGY; HUMAN; HYSTERECTOMY; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MYOMETRIUM; PARAAORTIC LYMPH NODE; PELVIS LYMPH NODE; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; SALPINGOOOPHORECTOMY; TUMOR INVASION; CARCINOMA; ENDOMETRIAL NEOPLASMS; MIDDLE AGED; PATHOLOGY; PERITONEUM; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; DISEASE-FREE SURVIVAL; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; PERITONEUM; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES;

EID: 84900458262     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1097/IGC.0000000000000072     Document Type: Article

References (22)

1. Pecorelli S. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet. 2009;105:103-104.
2. Creasman W. Revised FIGO staging for carcinoma of the endometrium. Int J Gynaecol Obstet. 2009;105:109.
3. Mariani A, Dowdy SC, Podratz KC. New surgical staging of endometrial cancer: 20 years later. Int J Gynaecol Obstet. 2009;105:110-111.
4. Takeshima N, Nishida H, Tabata T, et al. Positive peritoneal cytology in endometrial cancer: enhancement of other prognostic indicators. Gynecol Oncol. 2001;82:470-473.
5. Mariani A, Webb MJ, Keeney GL, et al. Assessment of prognostic factors in stage IIIA endometrial cancer. Gynecol Oncol. 2002;86:38-44.
6. Fadare O, Mariappan MR, Hileeto D, et al. Upstaging based solely on positive peritoneal washing does not affect outcome in endometrial cancer. Mod Pathol. 2005;18:673-680.
7. Saga Y, Imai M, Jobo T, et al. Is peritoneal cytology a prognostic factor of endometrial cancer confined to the uterus? Gynecol Oncol. 2006;103:277-280.
8. Havrilesky LJ, Cragun JM, Calingaert B, et al. The prognostic significance of positive peritoneal cytology and adnexal/serosal metastasis in stage IIIA endometrial cancer. Gynecol Oncol. 2007;104:401-405.
9. Havrilesky LJ, Secord AA, O'Malley DM, et al. Multicenter analysis of recurrence and survival in stage IIIA endometrial cancer. Gynecol Oncol. 2009;114:279-283.
10. Wethington SL, Barrena Medel NI, Wright JD, et al. Prognostic significance and treatment implications of positive peritoneal cytology in endometrial adenocarcinoma: unraveling a mystery. Gynecol Oncol. 2009;115:18-25.
11. Cooke EW, Pappas L, Gaffney DK. Does the revised International Federation of Gynecology and Obstetrics staging system for endometrial cancer lead to increased discrimination in patient outcomes? Cancer. 2011;117:4231-4237.
12. Yanoh K, Takeshima N, Hirai Y, et al. Identification of a high-risk subgroup in cytology-positive stage IIIA endometrial cancer. Acta Cytol. 2001;45:691-696.
13. Gemignani ML, Curtin JP, Zelmanovich J, et al. Laparoscopic-assisted vaginal hysterectomy for endometrial cancer: clinical outcomes and hospital charges. Gynecol Oncol. 1999;73:5-11.
14. Frigerio L, Gallo A, Ghezzi F, et al. Laparoscopic-assisted vaginal hysterectomy versus abdominal hysterectomy in endometrial cancer. Int J Gynaecol Obstet. 2006;93:209-213.
15. Kalogiannidis I, Lambrechts S, Amant F, et al. Laparoscopy-assisted vaginal hysterectomy compared with abdominal hysterectomy in clinical stage I endometrial cancer: safety, recurrence, and long-term outcome. Am J Obstet Gynecol. 2007;196:248.e1-248.e8.
16. Sonoda Y, Zerbe M, Smith A, et al. High incidence of positive peritoneal cytology in low-risk endometrial cancer treated by laparoscopically assisted vaginal hysterectomy. Gynecol Oncol. 2001;80:378-382.
17. Eltabbakh GH, Mount SL. Laparoscopic surgery does not increase the positive peritoneal cytology among women with endometrial carcinoma. Gynecol Oncol. 2006;100:361-364.
18. Momeni M, Kolev V, Cardenas-Goicoechea J, et al. Does the type of surgery for early-stage endometrial cancer affect the rate of reported lymphovascular space invasion in final pathology specimens? Am J Obstet Gynecol. 2013;208:71.e1-71.e6.
19. Müller A, Homey B, Soto H, et al. Involvement of chemokine receptors in breast cancer metastasis. Nature. 2001;410:50-56.
20. Kodama J, Hasengaowa, Kusumoto T, et al. Association of CXCR4 and CCR7 chemokine receptor expression and lymph node metastasis in human cervical cancer. Ann Oncol. 2007;18:70-76.
21. Jiang YP, Wu XH, Shi B, et al. Expression of chemokine CXCL12 and its receptor CXCR4 in human epithelial ovarian cancer: an independent prognostic factor for tumor progression. Gynecol Oncol. 2006;103:226-233.
22. Shiozaki T, Tabata T, Ma N, et al. Association of CXC chemokine receptor type 4 expression and clinicopathologic features in human vulvar cancer. Int J Gynecol Cancer. 2013;23:1111-1117.